Literature DB >> 16080530

Active succinate dehydrogenase (SDH) and lack of SDHD mutations in sporadic paragangliomas.

Simone Braun1, Kathrin Riemann, Susan Kupka, Peter Leistenschneider, Karl Sotlar, Heide Schmid, Nikolaus Blin.   

Abstract

BACKGROUND: Paragangliomas are benign, slow-growing tumours of the head and neck region. The candidate gene for familial and some sporadic paragangliomas, SDHD (succinate dehydrogenase, subunit D), has been mapped to the PGL1 locus in 11q23.3.
MATERIALS AND METHODS: Normal and tumour DNA of 17 patients with sporadic paragangliomas were analysed by sequencing (SDHD, SDHB and SDHC genes), fluorescence in situ hybridisation (FISH). In addition, loss of heterozygosity (LOH) and succinate dehydrogenase (SDH) enzyme activity assays were performed. RESULTS AND
CONCLUSION: Only two patients from our collective showed SDH gene mutations, one in SDHD and one in SDHB, respectively. Moreover, SDH activity detected in 5/8 patients confirmed the fact that SDH inactivation is not a major event in sporadic paragangliomas. LOH and FISH analysis demonstrated a frequent loss of regions within chromosome 11, indicating that additional genes in 11q may play a role in tumour genesis of sporadic paragangliomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080530

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.

Authors:  Magdalena Gorska-Ponikowska; Alicja Kuban-Jankowska; Stephan A Eisler; Ugo Perricone; Giosuè Lo Bosco; Giampaolo Barone; Stephan Nussberger
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

Review 2.  [Dignity of carotid body tumors. Review of the literature and clinical experiences].

Authors:  D Grotemeyer; S M Loghmanieh; S Pourhassan; T A Sagban; F Iskandar; P Reinecke; W Sandmann
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

Review 3.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

4.  Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma.

Authors:  Alexander Weber; Michael M Hoffmann; Hartmut P H Neumann; Zoran Erlic
Journal:  Horm Cancer       Date:  2012-05-10       Impact factor: 3.869

5.  The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.

Authors:  Jean-Pierre Bayley; Peter Devilee; Peter E M Taschner
Journal:  BMC Med Genet       Date:  2005-11-16       Impact factor: 2.103

6.  Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.

Authors:  Marc Bennedbæk; Maria Rossing; Åse K Rasmussen; Anne-Marie Gerdes; Anne-Bine Skytte; Uffe B Jensen; Finn C Nielsen; Thomas V O Hansen
Journal:  Hered Cancer Clin Pract       Date:  2016-06-08       Impact factor: 2.857

7.  LOH on chromosome 11q, but not SDHD and Men1 mutations was frequently detectable in Chinese patients with pheochromocytoma and paraganglioma.

Authors:  Hai-Yan Sun; Bin Cui; Din-Wei Su; Xiao-Long Jin; Fu-Kang Sun; Yu Zu; Lei Jiang; Wei-Qing Wang; Guang Ning
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

Review 8.  Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas.

Authors:  Arthur S Tischler
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

9.  A multidisciplinary approach to carotid body tumors surgical management.

Authors:  David Fan; Stephanie Luster; Ibrahim G Eid; Abdul Saied Calvino
Journal:  J Surg Case Rep       Date:  2020-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.